|
|
|
Volumn 16, Issue 8 Suppl 7, 2002, Pages 33-40
|
|
Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CARBAMAZEPINE;
DRUG DERIVATIVE;
IRINOTECAN;
PHENYTOIN;
ARTICLE;
BRAIN TUMOR;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG INTERACTION;
FEMALE;
GLIOMA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MAXIMUM TOLERATED DOSE;
MORTALITY;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PROBABILITY;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANTICONVULSANTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BRAIN NEOPLASMS;
CAMPTOTHECIN;
CARBAMAZEPINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
GLIOMA;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MAXIMUM TOLERATED DOSE;
PHENYTOIN;
PROBABILITY;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0036676381
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (47)
|
|
References (0)
|
